期刊文献+

部分抗结核分枝杆菌药物的耐药机理研究进展 被引量:7

Advances in reseach on M y cobacterium tuberculosis drug resistance mechanism
下载PDF
导出
摘要 结核病是危害严重的重大传染病之一,抗结核药物的应用在治疗结核病的过程中具有重要意义。然而抗结核药物治疗不当会引起耐多药和广泛耐药结核分枝杆菌的出现,导致结核病抬头。结核的耐药多与耐药基因突变有关,笔者总结了常见抗结核药物的耐药分子机制的研究进展,为耐药结核的诊断和治疗提供分子依据。 Tuberculosis was one of most serious infectious diseases that were harmful to human health.Antibiotics was effective treatment against this bacterium.But the emergency of multi-and extensively drug-resistant Mycobacterium tuberculosis(Mtb) were occurred frequently when the use of antibiotics was unproper.Drug-resistant phenotype was due to mutations in drug resistant related genes,this paper will state the progress in mechanism study of drug resistant Mtb,which will guide the diagnosis and treatment of drug resistant Mtb.
出处 《中国防痨杂志》 CAS 2013年第8期615-620,共6页 Chinese Journal of Antituberculosis
基金 "十二五"国家科技重大专项(2012ZX10004501)
关键词 抗结核药 抗生素类 抗结核 抗药性 细菌 Antitubercular agents Antibiotics antitubercular Drug resistance bacterial
  • 相关文献

参考文献47

  • 1王黎霞,成诗明,陈明亭,赵雁林,张慧,姜世闻,何广学,吕青,杜昕,陈伟,刘小秋,阮云洲,王胜芬,夏愔愔,于兰,李峻,李雪,王宇,无.2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志,2012,34(8):485-508. 被引量:2427
  • 2Wirth T, Hildebrand F, Allix-Bfiguec C, et al. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog,2008,4(9) :e1000160.
  • 3Motiwala AS, Dai Y, Jones-Lopez EC,et al. Mutations in ex- tensively drug resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms. J Infect Dis, 2010, 201 (6) : 881-888.
  • 4Marttila HJ, Soini H, Eerola E, et al. A Ser315 Thr substitu tion in katG is predominant in genetically heterogeneous multi- drug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicroh Agents Chemother, 1998,42(9) : 2443-2445.
  • 5Coll P, Aragon LM, Alcaide F,et al. Molecular analysis of iso niazid and rifampin resistance in Mycobacterium tuberculosis iso- lates recovered from Barcelona. Microb Drug Resist, 2005,11 (2) : 107-114.
  • 6Haas WH, Schilke K, Brand J, et al. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob Agents Chemother, 1997,41 (7) : 1601-1603.
  • 7Musser JM, Kapur V, Williams DL, et al. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isonia zid resistant and susceptible strains of Mycobacterium tubercu- losis by automated DNA sequencing: restricted array of muta- tions associated with drug resistance. J Infect Dis, 1996, 173 (1) : 196-202.
  • 8Rouse DA, Morris SL. Molecular mechanisms of isoniazid re-sistance in Mycobacterium tuberculosis and Mycobacterium boris. Infeet Imrnun, 1995,63 (4) : 1427-1433.
  • 9Lee AS, Tang LL, Lim IH, et al. Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore. J Infect Dis, 1997,176(4) : 1125-1126.
  • 10Cockerill FR 3rd, Uhl JR, Temesgen Z, et al. Rapid identifi- cation of a point mutation of the Mycobacterium tuberculosis cata- lase-peroxidase(KatG) gene associated with isoniazid resist- ance. J Infect Dis,1995,171(1):240 245.

二级参考文献85

共引文献2479

同被引文献90

  • 1袁磊凌,李家政,邹远华,吴智龙.佛山市涂阳肺结核患者耐药情况分析[J].结核病与肺部健康杂志,2014,3(1):40-45. 被引量:10
  • 2高凌玉,周建琴,孙承航.抗结核候选新药PA-824的研究进展[J].国外医药(抗生素分册),2006,27(6):241-244. 被引量:8
  • 3Zhao Y, Xu S, Wang L, et al. National survey of drug resis tant tuberculosis in China. N Engl J Med, 2012, 366 (23): 2161-2170.
  • 4Louw GE, Warren RM, Gey van Pittius NC, et al. A balan- cing act:efflux/influx in mycobacterial drug resistance. Anti- microb Agents Chemother, 2009,53(8): 3181-3189.
  • 5Supply P, Allix C, Lesjean S, et al. Proposal for standardiza- tion of optimized mycobacterial interspersed repetitive unit variable-number tandem repeat typing of Mycobacterium tuber- culosis. J Clin Microbiol, 2006,44(12): 4498- 4510.
  • 6Leonard B, Coronel J, Siedner M, et al. Inter- and intra-assay reproducibility of microplate Alamar blue assay results for iso- niazid, rifampicin, ethambutol, streptomycin, eiprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol, 2008,46(10) : 3526-3529.
  • 7Gupta AK, Katoeh VM, Chauhan DS, et al. Mieroarray ana- lysis of efflux pump genes in multidrug resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Mierob Drug Resist, 2010,16(1): 21-28.
  • 8Baysarowich J, Koteva K, Hughes DW, et al. Rifamycin anti- biotic resistance by ADP-ribosylation: Structure and diversity of Arr. Proc Natl Acad Sci U S A, 2008, 105 (12): 4886 -4891.
  • 9Surcouf C, Heng S, Pierre-Audigier C, et al. Molecular detec tion of fluoroquinolone-resistance in multi-drug resistant tuber- culosis in Cambodia suggests low association with XDR pheno- types. BMC Infect Dis,2011, (11):255.
  • 10Von Groll A, Martin A, Jureen P, et al. Fluoroquinolone re- sistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother, 2009, 53 ( 10): 4498 -4500.

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部